>fig|379.140.peg.207 Type IV prepilin peptidase TadV/CpaA
ATGGCGGCCTTCTCGGATCTGTTCACCATGACGATCCCGAACCGTATTTCCCTGATCCTTGTTGTCTCTTTCCTCGCACTGGCGCCGTTTTTTGGTCTCGGCCTGCAGGCGATCGGCACGCATCTTGCCGCCGGCGCGATCGTCTTTGCCGCATGCTTCGCTCTTTTTGCCTTTAATGTGATGGGCGGCGGAGACGCAAAACTGTTGACCGCCACCGCGCTCTGGTTCGGTCTGAACGAATCCCTGCTTTTCCTGATGACCGATGTTGCCATTATCGGCGGCCTCCTTACCCTGCTCATCCTGCTGGTGAGGGGACAGTCGAATACCATCCTTGCGATCGGACTGCCGGTGCCGAACTCTTTGCTGCTCGCCAAGAAGATCCCCTACGGCATCGCCATCGCGATCGGAGGCTTCATGGCCTTCCCGTCCTCGCCGCTCTTCATCGCTGCGCTGGAAAGCTTGAAATAA
>fig|379.159.peg.209 Type IV prepilin peptidase TadV/CpaA
ATGATCGCAGCTGCAGTCTTTGTCATACTGCCACTCTGCCTCGCCATGGCGGCCTTCTCGGATCTGTTCACCATGACGATCCCGAACCGTATTTCCCTGATCCTTGTTGTCTCTTTTCTCGCACTGGCGCCGTTTTTTGGTCTCGGCCTGCAGGCGATCGGCACGCATCTTGCCGCCGGCGCGATCGTCTTTACCGCATGCTTCGCTCTTTTTGCCTTTAATGTGATGGGCGGCGGAGACGCAAAACTGTTGACCGCCACCGCGCTCTGGTTCGGCTTGAACGAATCCCTGCTTTTCCTGATGACCGATGTTGCCATTATCGGCGGCCTCCTTACCCTGCTCATCCTGCTGGTGAGGGGACAGTCGAATACCATCCTTGCGATCGGACTGCCGGTGCCGAACTCTTTGCTGCTCGCCAAGAAGATCCCATACGGCATCGCCATCGCGATCGGTGGCTACATGGCCTTCCCGTCCTCGCCGCTCTTCATCGCTGCACTGGAAAGCCTGAAATAA
